Bacterial Menigitis and Deafness

J Gordon Millichap

doi:10.15844/pedneurbriefs-2-10-7

Bacterial Menigitis and Deafness

Pediatric Neurology Briefs

Volume 2 (1988): Issue 10

By: J Gordon Millichap

Open Access

|Oct 1988

Abstract

Dexamethasone (.15 mg/kg/bwt q 6 hr for 4 days) was considered beneficial in the treatment of infants and children with bacterial meningitis, particularly in preventing deafness, in two double blind, placebo-controlled trials involving 200 patients treated in the Dept of Pediatrics, University of Texas at Southwestern Medical Center, Dallas, TX.

References

Lebel MH Freij BJ Syrogiannopoulos GA Chrane DF Hoyt MJ Stewart SM Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials N Engl J Med 1988 Oct 13 319 15 964 71 3047581
Search in Google Scholar Back to article
Smith AL Neurologic sequelae of meningitis N Engl J Med 1988 Oct 13 319 15 1012 4 10.1056/NEJM198810133191510 3419468
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-2-10-7 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 77 - 78

Published on: Oct 1, 1988

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Bacterial Menigitis,

Dexamethasone,

Auditory Acuity

© 1988 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 2 (1988): Issue 10